documents: FDA-2023-P-5687-0003

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2023-P-5687-0003 FDA FDA-2023-P-5687 Interim Response Letter from FDA CDER to Bionpharma, Inc. Other Response(s) 2024-06-20T04:00:00Z 2024 6 2024-06-20T04:00:00Z   2024-06-20T13:18:57Z   0 0 09000064865c0a3b

Links from other tables